Mast Therapeutics (MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Mast Therapeutics (NYSE: MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioCryst Pharma (BCRX) Shares Ramp to Session Highs Amid Upcoming Galidesivir Data Presentation
- Equity and Commodity Markets
- Volatility and Volume movement
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesRodman & Renshaw
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!